Patents by Inventor Jeffrey W. Warmke

Jeffrey W. Warmke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7915010
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: March 29, 2011
    Assignee: Merial Limited
    Inventors: Jeffrey W. Warmke, Youfeng Yang, Doris F. Cully, Michel J. Hamelin
  • Patent number: 7674586
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: March 9, 2010
    Assignee: Merial Limited
    Inventors: Jeffrey W. Warmke, Youfeng Yang, Doris F. Cully, Michel J. Hamelin
  • Patent number: 7541432
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: June 2, 2009
    Assignee: Merial Limited
    Inventors: Jeffrey W. Warmke, Youfeng Yang, Doris F. Cully, Michel J. Hamelin
  • Publication number: 20080286770
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.
    Type: Application
    Filed: January 5, 2007
    Publication date: November 20, 2008
    Inventors: Jeffrey W. Warmke, Youfeng Yang, Doris F. Cully, Michel J. Hamelin
  • Patent number: 7202054
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: April 10, 2007
    Assignee: Merial Limited
    Inventors: Jeffrey W. Warmke, Youfeng Yang, Doris F. Cully, Michel J. Hamelin
  • Patent number: 7033789
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Schistocerca americana (grasshopper) glutamate-gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding S. americana glutamate-gated chloride channels, substantially purified forms of associated S. americana glutamate-gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Schistocerca americana glutamate-gated chloride channels, which will be useful as insecticides.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: April 25, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Michel J. Hamelin, Jeffrey W. Warmke
  • Patent number: 7001734
    Abstract: DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the channel activity, and channel modulators are identified. Channel modulators are useful as insecticides and arachnicidic agents.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: February 21, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Leonardus H. T. Van Der Ploeg, Jeffrey W. Warmke
  • Publication number: 20030229215
    Abstract: The present invention relates in part to isolated nucleic acid molecules (polynucleotides) which encode Rhipicephalus sanguineus glutamate gated chloride channels. The present invention also relates to recombinant vectors and recombinant hosts which contain a DNA fragment encoding R. sanguineus glutamate gated chloride channels, substantially purified forms of associated R. sanguineus glutamate gated chloride channels and recombinant membrane fractions comprising these proteins, associated mutant proteins, and methods associated with identifying compounds which modulate associated Rhipicephalus sanguineus glutamate gated chloride channels, which will be useful as insecticides.
    Type: Application
    Filed: September 23, 2002
    Publication date: December 11, 2003
    Inventors: Jeffrey W. Warmke, Youfeng Yang, Doris F. Cully, Michel J. Hamelin
  • Patent number: 6358701
    Abstract: To date, L-glutamate-gated chloride (GluCl) channels have been observed only in invertebrate organisms. Modulators of this channel (either agonists or antagoinists) will interfere with neurotransmission. For example, agents such as avermectins activate the GluCl, causing paralysis due to blocking of neurotranmitter release, resulting in death of the organism. Because GluCl channels are invertebreate specific, they are excellent targets for the discovery of novel insecticides, anthelminths and parasiticides that will display a marked safety profile because of the lack of mechanism based toxicity in vertebrate organisms. The present specification discloses isolation of a cDNA clone from the cat flea Ctenocephalides felis (CfGluCl-1) that encodes a L-glutamate-gated chloride channel. Heterologous expression of CfGluCl-1 cRNA in Xenopus oocytes results in robust expression of a L-glutamate-gated chloride current and the channel is activated and potentiated by avermectins.
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: March 19, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Jeffrey W. Warmke, Doris F. Cully, Adrian Etter, Philip S. Paress, Charles J. Cohen, Richard Brochu
  • Patent number: 5688917
    Abstract: DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: November 18, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Joseph P. Arena, Guoping Feng, Linda M. Hall, Ken Liu, Leonardus H. T. Van Der Ploeg, Peiyi Wang, Jeffrey W. Warmke
  • Patent number: 5593864
    Abstract: DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: January 14, 1997
    Assignees: Merck & Co., Inc., The Research Foundation of State University of New York
    Inventors: Joseph P. Arena, Guoping Feng, Linda M. Hall, Ken Liu, Leonardus H. T. Van Der Ploeg, Peiyi Wang, Jeffrey W. Warmke
  • Patent number: 5550049
    Abstract: DNAs encoding voltage-activated cation channels have been cloned and characterized. The cDNA's have been expressed in recombinant host cells which produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the channel activity, and channel modulators are identified. Channel modulators are useful as insecticides and arachnicidic agents.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: August 27, 1996
    Assignee: Merck & Co., Inc
    Inventors: Leonardus H. T. Van Der Ploeg, Jeffrey W. Warmke